Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

  • Go to Emergencies.
  • Current language selection: EN

    Change language selection to:

  • Contact us:

    Campus Charité MitteCharitéplatz 1 (local address: Luisenstraße 13)
    10117 Berlin

    Campus Virchow-KlinikumAugustenburger Platz 1 (local address: Südring 4)
    13353 Berlin

    Campus Benjamin FranklinHindenburgdamm 30 (local address: Haus V, Eingang West)
    12203 Berlin

  • Accessibility:
    Contrast Settings Change contrast
    Font size
    Font size bigger: STRG+ Font size smaller: STRG-

    You can enlarge or reduce the browser window. Please use CTRL and + to zoom in or CTRL and - to zoom out. Press CTRL and 0 to reset your browser window to normal size.

Open Menu
© Charité | Wiebke Peitz

Press release

18.09.2018

Pyotr Verzilov receiving treatment at Charité

Back to Overview

You are here:

Since his admission last weekend, Pyotr Verzilov has been receiving treatment at Charité – Universitätsmedizin Berlin Charité provided an update on his condition and treatment at a press conference on September 18, 2018.   

The patient was admitted to Charité with symptoms of poisoning and in a state of confusion. After admission, Pyotr Verzilov underwent a thorough examination, and is now receiving treatment in an intensive care unit.   

Prof. Dr. Karl Max Einhäupl, Charité’s Chief Executive Officer: “Pyotr Verzilov’s health is improving daily and he is no longer at risk. We are confident he will make a full recovery.” He adds: “Our colleagues in Moscow provided good initial treatment and have been very cooperative.”

Prof. Dr. Kai-Uwe Eckardt, Head of the Medical Clinic, Division of Nephrology and Internal Intensive Care Medicine: “We are now working on the assumption that he was poisoned nearly a week ago. Clinical findings suggest a particular group of substances was involved, but the substance itself remains unknown. Following consultation with toxicology experts, we have initiated a broad range of tests.”

It is not certain how much longer the patient will need to remain in hospital, though this is likely to become clear over the next few days.

Contact

Manuela Zingl
Press Officer
Charité – Universitätsmedizin Berlin
Tel: +49 30 450 570 400



Back to Overview